Pathology/Lab Coding Alert

ICD-10:

D05: Breast Cancer 'In situ' Expands Beyond 233.0

Update ER/PR status codes, too. You'll face significant changes in how you report in situ breast cancers once ICD-10 goes into effect -- even if you'll have a little longer to prepare for the switch. Don't forget: CMS has announced a proposed implementation date delay from Oct. 1, 2013 for the new diagnosis code set. The new implementation date is not yet finalized. Look for Specific Type, Location in ICD-10 While ICD-9 provides just one code for in situ breast cancer (233.0, Carcinoma in situ of breast), you'll have 12 codes to choose from when ICD-10 goes into effect. The new code set divides these cancers into four categories by "type": lobular, intraductal, other specified, and unspecified. You'll also need to designate whether the tumor is from the left, right, or unspecified breast. Here are the ICD-10 crosswalk code choices for 233.0: D05.00 -- Lobular carcinoma in situ of unspecified breast D05.01 -- [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pathology/Lab Coding Alert

View All